Genoma Lab Intl Stock Price, News & Analysis
Company Description
Genoma Lab Intl (OTC Link: GNMLF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $1.1B.
GNMLF stock has declined 11.2% over the past year. Shares last traded at $1.08.
This page provides a comprehensive overview of GNMLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Genoma Lab Intl (GNMLF) stock last traded at $1.08. Over the past 12 months, the stock has lost 11.2%. At a market capitalization of $1.1B, GNMLF is classified as a small-cap stock with approximately 1.0B shares outstanding.
Latest News
Genoma Lab Intl has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include earnings. View all GNMLF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Genoma Lab Intl (GNMLF) currently stands at 4.2 million shares, down 5.0% from the previous reporting period, representing 0.6% of the float. Over the past 12 months, short interest has increased by 205%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Genoma Lab Intl (GNMLF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
GNMLF Company Profile & Sector Positioning
Genoma Lab Intl (GNMLF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing GNMLF often look at related companies in the same sector, including Evotec Se (EVOTF), Nika Pharmaceuticals (NIKA), Trulieve Cannabis Corp (TCNNF), Green Thum (GTBIF), and Endo Inc (NDOI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GNMLF's relative position within its industry.